This content is machine translated Undesirable pigments Tattoo removal Like many things, the acceptance of tattoos is subject to social changes and time currents. Obviously, for thousands of years, people have felt the need to use tattoos to differentiate… CME-Test
View Post 4 min This content is machine translated Case series Topical therapy of scalp psoriasis Treatment of the capillitium often presents a particular challenge in topical therapy. In addition to the condition of the skin, the patient’s preferences are also an important criterion in choosing…
View Post 6 min This content is machine translated Atopic dermatitis Modern systems therapeutics specifically regulate the excessive immune response The therapeutic landscape for patients with moderate to severe atopic dermatitis is changing. In the multifactorial pathogenesis of this chronic recurrent dermatosis, an impaired immune response plays a central role.…
View Post 16 min This content is machine translated Expanding the treatment options for hair loss Combination of PRP and mesotherapy with NWM MesoHair The topic of hair loss is playing an increasingly important role in dermatology. More and more patients – especially females – do not want to accept the fact that their… CME-Test
View Post 5 min This content is machine translated Epidemiological study Dermatophyte infections in children and adults A German research team evaluated the findings of mycological dermatophyte cultures according to identified pathogen, clinical picture, and sociodemographic factors in a retrospective multicenter study. The 2021 in the Journal…
View Post 5 min This content is machine translated Atopic dermatitis Tralokinumab – another biologic with an excellent benefit-risk profile Since the beginning of June this year, tralokinumab – a human monoclonal IgG4 antibody that specifically binds with high affinity to the cytokine IL-13 – has been approved for adults…
View Post 4 min This content is machine translated Hidradenitis suppurativa: study report Successful treatment demonstrably improves quality of life Adalimumab (anti-TNF-α) is currently still the only approved biologic for the treatment of moderate to severe hidradenitis suppurativa (HS). In a recent “real world” 52-week study, treatment with adalimumab resulted…
View Post 4 min This content is machine translated Psoriatic Arthritis Current GRAPPA recommendations revisited An important message from the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) is that patients with psoriatic arthritis (PsA) should be treated on an individualized basis…
View Post 5 min This content is machine translated Nail psoriasis A diagnostic challenge Nail psoriasis is the most common inflammatory dermatosis of the nail apparatus. Most often, but not always, nail infestation occurs together with skin psoriasis. Typical psoriasiform nail changes include spotted…
View Post 4 min This content is machine translated Bullous pemphigoid Updated European expert guideline published The Autoimmune blistering diseases Task Force of the European Academy of Dermatology and Venereology (EADV) recently issued new recommendations for the treatment of bullous pemphigoid. The consensus expert opinion is based…
View Post 3 min This content is machine translated Atopic dermatitis The JAK/STAT pathway as a therapeutic target. Janus kinase (JAK) inhibitors inhibit signal transduction of numerous proinflammatory cytokines with varying selectivity. With baricitinib, upadacitinib and abrocitinib, three oral JAK inhibitors are currently approved in Switzerland for the…
